This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Liver/ Biliary Tract/ Pancreatic Diseases  • Viral Infections  • Transplantation  • Liver Transplantation  • Alert me on articles by topic

Amy N. Ship, MD

JAMA. 2005;293:2027.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In a Clinical Crossroads held at Medicine Grand Rounds in March 2003, Dr Douglas Hanto discussed the case of Mr G, a 50-year-old man needing liver transplantation.¹ Mr G had hepatitis C and cirrhosis and had been treated with ribavirin and interferon unsuccessfully. He had 2 episodes of bleeding from esophageal varices and had undergone a transjugular intrahepatic portosystemic shunt (TIPS) procedure. At the time of the conference, Mr G was receiving disability due to significant fatigue, difficulty concentrating, and poor memory. His model end-stage liver disease (MELD) score was 18.

Dr Hanto reviewed the indications and contraindications to liver transplantation; the pretransplant evaluation, options, and listing; the medical management of hepatitis C and cirrhosis; the medical and surgical issues; and prognosis after transplantation. Dr Hanto observed that Mr G and his family had adjusted to his chronic illness, and that his relatively modest symptoms and . . . [Full Text of this Article]

MR G